Evidence map›Paper›PMID 38498576›Full record

ArticlePLoS genetics2024

Altered Fhod3 expression involved in progressive high-frequency hearing loss via dysregulation of actin polymerization stoichiometry in the cuticular plate.

Ely Cheikh Boussaty, Yuzuru Ninoyu, Leonardo R Andrade, Qingzhong Li, Ryu Takeya, Hideki Sumimoto, Takahiro Ohyama, Karl J Wahlin, Uri Manor, Rick A Friedman

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ely Cheikh BoussatyDepartment of Otolaryngology-Head and Neck Surgery, University of California, San Diego, La Jolla, California, United States of America.ORCID 0000-0003-3146-8821
Yuzuru NinoyuDepartment of Otolaryngology-Head and Neck Surgery, University of California, San Diego, La Jolla, California, United States of America.
Leonardo R AndradeWaitt Advanced Biophotonics Center, Salk Institute for Biological Studies, La Jolla, California, United States of America.
Qingzhong LiUSC-Tina and Rick Caruso Department of Otolaryngology-Head & Neck Surgery, Zilkha Neurogenetic Institute, USC Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Ryu TakeyaDepartment of Pharmacology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.ORCID 0000-0002-9987-1513
Hideki SumimotoDepartment of Biochemistry, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Takahiro OhyamaUSC-Tina and Rick Caruso Department of Otolaryngology-Head & Neck Surgery, Zilkha Neurogenetic Institute, USC Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Karl J WahlinShiley Eye Institute, University of California, San Diego, San Diego, California, United States of America.
Uri ManorWaitt Advanced Biophotonics Center, Salk Institute for Biological Studies, La Jolla, California, United States of America.ORCID 0000-0002-9802-1955
Rick A FriedmanDepartment of Otolaryngology-Head and Neck Surgery, University of California, San Diego, La Jolla, California, United States of America.ORCID 0000-0002-5490-8562
University of California San Diego · USSalk Institute for Biological Studies · USUniversity of Southern California · USKyushu University · JPUniversity of Miyazaki · JP

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Reuben Shaw · 1985 to 2026
$82.8M
San Diego Nathan Shock CenterP30AG068635 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SHADEL, GERALD · 2020 to 2024
$6.0M
Investigating the mechanisms of stereocilia length regulation and innovative strategies for restoring hearingR01DC021075 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Uri Manor · 2023 to 2026
$3.2M
The genetic basis for age-related hearing loss in outbred miceR01DC018566 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FRIEDMAN, RICK A · 2020 to 2024
$2.7M
Pluripotent Stem Cell Derived 3D Retinas for Studies of Early Onset Retinal DegenerationR01EY031318 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WAHLIN, KARL J · 2020 to 2024
$2.4M
A Novel Model System for Restoring Hearing in vivoR21DC018237 · NIDCD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI COLEMAN, TODD P, KYRIAKAKIS, PHILLIP · 2020 to 2021
$505k
NCI NIH HHS P30 CA014195NEI NIH HHS R01 EY031318NIA NIH HHS P30 AG068635NIDCD NIH HHS R01 DC018566NIDCD NIH HHS R01 DC021075NIDCD NIH HHS R21 DC018237NSF NeuroNex Award 2014862
6 · The paper itself

Abstract

Age-related hearing loss (ARHL) is a common sensory impairment with complex underlying mechanisms. In our previous study, we performed a meta-analysis of genome-wide association studies (GWAS) in mice and identified a novel locus on chromosome 18 associated with ARHL specifically linked to a 32 kHz tone burst stimulus. Consequently, we investigated the role of Formin Homology 2 Domain Containing 3 (Fhod3), a newly discovered candidate gene for ARHL based on the GWAS results. We observed Fhod3 expression in auditory hair cells (HCs) primarily localized at the cuticular plate (CP). To understand the functional implications of Fhod3 in the cochlea, we generated Fhod3 overexpression mice (Pax2-Cre+/-; Fhod3Tg/+) (TG) and HC-specific conditional knockout mice (Atoh1-Cre+/-; Fhod3fl/fl) (KO). Audiological assessments in TG mice demonstrated progressive high-frequency hearing loss, characterized by predominant loss of outer hair cells, and a decreased phalloidin intensities of CP. Ultrastructural analysis revealed loss of the shortest row of stereocilia in the basal turn of the cochlea, and alterations in the cuticular plate surrounding stereocilia rootlets. Importantly, the hearing and HC phenotype in TG mice phenocopied that of the KO mice. These findings suggest that balanced expression of Fhod3 is critical for proper CP and stereocilia structure and function. Further investigation of Fhod3 related hearing impairment mechanisms may lend new insight towards the myriad mechanisms underlying ARHL, which in turn could facilitate the development of therapeutic strategies for ARHL.

Indexed as

ActinsHearing Loss, High-FrequencyAnimalsCochleaForminsGenome-Wide Association StudyHearingMiceMice, KnockoutPolymerizationActinsFhod3 protein, mouseFormins

Identifiers

PMID38498576
PMCPMC10977885
OpenAlexW4392928400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.